Sangamo receives Nasdaq deficiency notice for bid price below $1.00; 180 days to cure

SANGAMO THERAPEUTICS, INC

On April 30, 2025, Nasdaq notified Sangamo that its stock closed below $1.00 for 30 consecutive business days.
Company has until October 27, 2025 to regain compliance by closing at $1.00+ for 10 consecutive days.
If not compliant, may qualify for a second 180-day period if other listing standards are met.
Failure to cure could result in delisting from the Nasdaq Capital Market.
Sangamo will monitor bid price and evaluate options including a reverse stock split.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.